Prevalence and clinical characteristics of obsessive-compulsive disorder and obsessive compulsive symptoms in Afrikaner schizophrenia and schizoaffective disorder patients

African Journal of Psychiatry (South Africa)

Volumn 10, Issue 4, 2007, Pages 219-224

  Seedat, F ^a   Roos, J L ^a   Pretorius, H W ^a   Karayiorgou, M ^b   Nel, B ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b NewYork Presbyterian Hospital   (United States)

Author keywords

Afrikaner population; Obsessive compulsive disorder (OCD); Obsessive compulsive symptoms (OCS); Schizoaffective disorder; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ADDICTION; ADOLESCENT; ADULT; ALCOHOL ABUSE; ARTICLE; CANNABIS ADDICTION; CHILD; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; CULTURAL FACTOR; DIAGNOSTIC INTERVIEW FOR GENETIC STUDIES; ETHNIC DIFFERENCE; FEMALE; HEREDITY; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OBSESSIVE COMPULSIVE DISORDER; ONSET AGE; PREVALENCE; PROGNOSIS; RITUAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHOOL CHILD; SUBSTANCE ABUSE; SUICIDAL IDEATION; SUICIDE ATTEMPT;

EID: 58149152787     PISSN: 19948220     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Rosen I. The clinical significance of obsessions in schizophrenia. J Ment S 1957; 103:773-785.
2. Fenton WS, McGlashan TN. The prognostic significance of obsessive-compulsive symptoms in schizophrenia. Am J Psychiatry 1986; 143:437-441.
3. Berman I, Kalinowski A, Berman SM, et al. Obsessive and compulsive symptoms in chronic schizophrenia. Compr Psychiatry 1995; 36:6-10.
4. Poyurovsky M, Weizman A, Weizman R. Obsessive-compulsive disorder in schizophrenia:clinical characteristics and treatment. CNS Drugs 2004;18(14):990-1010.
5. Karno M, Golding JM, Sorenson SB, et al. The epidemiology of obsessive-compulsive disorder in five US communities. Arch Gen Psychiatry 1998 Dec; 45(12): 1094-1099.
6. Yaryura-Tobias JA, Campisi TA, McKay D, et al. Schizophrenia and obsessive-compulsive disorder: shared aspects of pathology. Neurol Psychiatry Brain Res 1995;3:143-148.
7. Tibbo P, Warneke L. Obsessive-compulsive disorder in schizophrenia: epidemiologic and biologic overlap. J Psychiatry Neuroscience 1999;24:15-24.
8. Hwang MY, Opler LA. Management of schizophrenia with obsessive-compulsive disorder. Psychiatr Ann 2000;30:23-28.
9. M Poyurovsky, LM Koran. Obsessive-compulsive disorder (OCD) with schizotypy vs. schizophrenia with OCD: diagnostic dilemmas and therapeutic implications. Journal of Psychiatric Research 2005;39:399-408.
10. Emsley RA, Roberts MC, Rataemane S, et al. Ethnicity and treatment response in schizophrenia: a comparison of 3 ethnic groups. J Clin Psychiatry 2000; 63:9-14.
11. Weismann MM, Bland RC, Canino GJ, et al. The cross national epidemiology of obsessive-compulsive disorder. The Cross National Collaborative Group. J Clin Psychiatry 1994;55:suppl, 5-10.
12. Niehaus DJH, Koen L, Muller J, et al. Obsessive compulsive disorder-prevalence in Xhosa-speaking schizophrenia patients. SAMJ, Feb 2005;vol 95, No 2:120-122.
13. Hwang MY, Morgan JE, Losconzco MF. Clinical and neuropsychological profiles of obsessive-compulsive schizophrenia: a pilot study. J Neuropsychiatry Clin Neuroci 2000;12:91-94.
14. Sobin C, Roos JL, Pretorius HW, et al. A comparison study of early non-psychotic deviant behaviour in Afrikaner and US patients with schizophrenia and schizoaffective disorder. Psychiatry Res 2003;117:113-125.
15. Roos JL, HW Pretorius, M Karayiorgou et al. Cannabis and other variables affecting age at onset in a schizophrenia founder population. S Afr. Psychiatry Rev 2006;9:99-103.
16. Veen ND, Selten JP, Van der Tweel I, et al. Cannabis use and age of onset of schizophrenia. Am J Psychiatry 2004:501-506.
17. Karayiorgou M, Torrington M, Abecasis GR, et al. Phenotypic characterization and genealogical tracing in an Afrikaner schizophrenia database. Am J Med Genet 2004;124B:20-28.
18. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington DC: American Psychiatric Association, 1994.
19. Nurnberger JI, Blehar MC, Kaufmann CA, et al. Diagnostic Interview for Genetic Studies: Rationale, unique features and training. Arch Gen Psychiatry 1994;51:849-859.
20. Dominquez RA, Backman KE, Lugo SC. Demographics, prevalence and clinical features of the schizo-obsessive subtype of schizophrenia. CNS Spectrums 1999;12:50-56.
21. Ozdemir O, Turkel R, Turksoy N, et al. Clinical characteristics in obsessive-compulsive disorder with schizophrenia. Comprehensive Psychiatry 2003;vol 44(4):311-316.
22. Tibbo P, Warnke L. Obsessive-compulsive disorder in schizophrenia: epidemiologic and biologic overlap. J Psychiatry Neuroscience 1999,Jan;24(1):15-24.
23. Gross-Isseroff R, Hermesh H, Zohar J, et al. Neuroimaging communality between schizophrenia and obsessive compulsive disorder: a putative basis for schizo-obsessive disorder. World J Biol Psychiatry 2003,Jul 4(3):129-134.
24. Poyurovsky M, Fuchs C, Faragian S, et al. Aggregation of obsessive-compulsive spectrum disorders in schizophrenia patients with obsessive-compulsive disorder. Canadian J Psychiatry 2006; 51(12):746-753.
25. Poyurovsky M, Hermesh H, Weizman A. Fluvoxamine treatment in clozapine induced obsessive-compulsive symptoms in schizophrenia patients. Clinical Neuropharmacology 1996;19:305-313.
26. Lykouras L, Zervas IM, Gournelius R, et al. Olanzapine and obsessive-compulsive symptoms. European Neuropsychopharmacology 2000;10:385-387.
27. Alevizos B, Lykouras L, Zervas IM, et al. Risperidone induced obsessive-compulsive symptoms: a series of 61 cases. Journal of Clinical Psychopharmacology 2002;22:461-467.